Use of thiazolidinedione and cancer risk in Type 2 diabetes: The Hong Kong diabetes registry

被引：10

作者：

Yang, Xilin ^{[1
,2
]}

So, Wing-Yee ^{[2
,3
,4
]}

Ma, Ronald C. W. ^{[2
,3
,4
]}

Yu, Linda W. L. ^{[5
]}

Kong, Alice P. S. ^{[2
,3
,4
]}

Lee, Heung Man ^{[2
,3
,4
]}

Xu, Gang ^{[2
,3
,4
]}

Ozaki, Risa ^{[2
,3
]}

Ko, Gary T. C. ^{[2
,3
]}

Chan, Juliana C. N. ^{[2
,3
,4
]}

机构：

[1] Tianjin Med Univ, Coll Publ Hlth, Dept Epidemiol, Tianjin 300070, Peoples R China

[2] Chinese Univ Hong Kong, Dept Med & Therapeut, Hong Kong, Hong Kong, Peoples R China

[3] Chinese Univ Hong Kong, Hong Kong Inst Diabet & Obes, Hong Kong, Hong Kong, Peoples R China

[4] Chinese Univ Hong Kong, Li Ka Shing Inst Hlth Sci, Hong Kong, Hong Kong, Peoples R China

[5] Hosp Author Headquarter, Hong Kong, Hong Kong, Peoples R China

来源：

DIABETES RESEARCH AND CLINICAL PRACTICE | 2012年 / 97卷 / 01期

关键词：

Thiazolidinediones; Cancer; Type; 2; diabetes; ROSIGLITAZONE; HYPERGLYCEMIA; PIOGLITAZONE; ASSOCIATIONS;

D O I：

10.1016/j.diabres.2012.03.006

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

We examined possible anticancer effects of thiazolidinediones (TZDs) in 6074 Chinese with Type 2 diabetes free of cancer at enrolment. During a median follow-up of 4.93 years, 270 patients developed cancer. Use of TZDs was associated with reduced risk of cancer in a dose-response manner in multivariable analysis. (C) 2012 Elsevier Ireland Ltd. All rights reserved.

引用

页码：E11 / E15

页数：5

共 50 条

[31] Intensive glucose control and risk of cancer in patients with type 2 diabetes
Stefansdottir, G.
Zoungas, S.
Chalmers, J.
Kengne, A. P.
Knol, M. J.
Leufkens, H. G. M.
Patel, A.
Woodward, M.
Grobbee, D. E.
De Bruin, M. L.
DIABETOLOGIA, 2011, 54 (07) : 1608 - 1614
[32] Association of hip fractures with cardiometabolic-renal risk factors in Southern Chinese patients with type 2 diabetes - the Hong Kong Diabetes Register
Cheung, Elaine Yun-Ning
Kong, Alice Pik-Shan
Lau, Eric Siu-Him
Chow, Elaine Yee-Kwan
Luk, Andrea On-Yan
Ma, Ronald Ching-Wan
Lam, Tsz Ping
Lee, Wayne Yuk-Wai
Cheng, Jack Chun-Yiu
Ebeling, Peter R.
Chan, Juliana Chung-Ngor
JOURNAL OF DIABETES INVESTIGATION, 2021, 12 (09) : 1739 - 1748
[33] Thiazolidinedione use is associated with reduced risk of dementia in patients with type 2 diabetes mellitus: A retrospective cohort study
Zhao, Houyu
Zhuo, Lin
Sun, Yexiang
Shen, Peng
Lin, Hongbo
Zhan, Siyan
JOURNAL OF DIABETES, 2023, 15 (02) : 97 - 109
[34] Polypharmacy and bone fracture risk in patients with type 2 diabetes: The Fukuoka Diabetes Registry
Komorita, Yuji
Ohkuma, Toshiaki
Iwase, Masanori
Fujii, Hiroki
Oku, Yutaro
Higashi, Taiki
Oshiro, Ayaka
Sakamoto, Wakako
Yoshinari, Masahito
Nakamura, Udai
Kitazono, Takanari
DIABETES RESEARCH AND CLINICAL PRACTICE, 2021, 181
[35] Use of metformin and risk of kidney cancer in patients with type 2 diabetes
Tseng, Chin-Hsiao
EUROPEAN JOURNAL OF CANCER, 2016, 52 : 19 - 25
[36] Rosiglitazone Use and the Risk of Bladder Cancer in Patients With Type 2 Diabetes
Han, Eugene
Jang, Suk-Yong
Kim, Gyuri
Lee, Yong-ho
Choe, Eun Yeong
Nam, Chung Mo
Kang, Eun Seok
MEDICINE, 2016, 95 (06)
[37] Circulating thrombospondin-2 level for identifying individuals with rapidly declining kidney function trajectory in type 2 diabetes: a prospective study of the Hong Kong West Diabetes Registry
Lee, Chi-Ho
Lui, David Tak-Wai
Cheung, Chloe Yu-Yan
Fong, Carol Ho-Yi
Yuen, Michele Mae-Ann
Chow, Wing-Sun
Xu, Aimin
Lam, Karen Siu-Ling
NEPHROLOGY DIALYSIS TRANSPLANTATION, 2023,
[38] Glycated hemoglobin, diabetes treatment and cancer risk in type 2 diabetes. A case-control study
Dabrowski, Mariusz
ANNALS OF AGRICULTURAL AND ENVIRONMENTAL MEDICINE, 2013, 20 (01) : 116 - 121
[39] Type 2 diabetes, thiazolidinediones, and cardiovascular risk
Taylor, Clare
Hobbs, F. D. Richard
BRITISH JOURNAL OF GENERAL PRACTICE, 2009, 59 (564): : 520 - 524
[40] Metformin Use Among Individuals at Risk for Type 2 Diabetes
Kuller, Lewis H.
CURRENT DIABETES REPORTS, 2012, 12 (03) : 265 - 273

← 1 2 3 4 5 →